US Patent 7414121 Chimeric, human and humanized anti-CSAp monoclonal antibodies
Patent 7414121 was granted and assigned to IMMUNOMEDICS, INC. on August, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
David M. Goldenberg0
Hans J. Hansen0
Edits on 14 Sep, 2023
Golden AI
Edits made to:
Article (+226 characters)
Article
Patent abstract
The present invention provides humanized, chimeric and human anti-CSAp antibodies and anti-CSAp antibody fusio proteins that are useful for the treatment and diagnosis of various cancers, including colon cancer.
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07414121 Chimeric, human and humanized anti-CSAp monoclonal antibodies US Patent 7414121 Chimeric, human and humanized anti-CSAp monoclonal antibodies
Infobox
Patent Number
074141210
Patent Number
74141210
Edits on 6 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074141210
Date of Patent
August 19, 2008
0Patent Application Number
110706970
Date Filed
March 3, 2005
0Official Website
Patent Primary Examiner
Edits on 9 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 1 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07414121 Chimeric, human and humanized anti-CSAp monoclonal antibodies
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07414121
Date of patent
August 19, 2008
Patent application number
11070697
Date Filed
March 3, 2005
Patent primary examiner
Find more entities like US Patent 7414121 Chimeric, human and humanized anti-CSAp monoclonal antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
